Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Magnetic detection of small entities
Method and device for reliable estimation of network traffic
Data unit receiver and sender control method
System and method for internet based procurement of goods and services
Electronic time stamping apparatus for use with an inground transmitter
  Randomly Featured Patents
Heat sink assembly
Method for turbocharging an internal combustion engine
Toy for animals
Cow bottle
Dual element read with shaped elements
Information processing apparatus, client apparatus, information processing system and service connection method
Astringent composition and method of use
Battery charging system having multiplexed charging functionality
Disposable dust bag for vacuum cleaner and the like
Line tightener